• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl bromides

Comprehensive Guide to Ethyl 3-bromoisoxazole-5-carboxylate (CAS 105174-97-8): Properties, Applications, and Industry Insights

Ethyl 3-bromoisoxazole-5-carboxylate (CAS 105174-97-8) is a versatile heterocyclic compound widely utilized in pharmaceutical and agrochemical research. This brominated isoxazole derivative features a carboxylate ester group, making it a valuable building block for synthesizing complex molecules. With the growing demand for isoxazole-based intermediates in drug discovery, this compound has gained significant attention in recent years. Researchers particularly value its reactivity in cross-coupling reactions and nucleophilic substitutions, which are crucial for developing novel bioactive compounds.

The structural uniqueness of Ethyl 3-bromoisoxazole-5-carboxylate lies in its isoxazole ring system, a five-membered heterocycle containing nitrogen and oxygen atoms. This architecture enables diverse chemical transformations, addressing current industry needs for multifunctional synthetic precursors. As the pharmaceutical sector increasingly focuses on targeted drug design and small molecule therapeutics, compounds like CAS 105174-97-8 have become essential tools for medicinal chemists. Its compatibility with modern green chemistry principles also aligns with sustainable development goals in chemical manufacturing.

Recent advancements in heterocyclic chemistry have highlighted the importance of 3-bromoisoxazole derivatives in developing innovative materials. The electron-withdrawing bromo group at the 3-position enhances the compound's reactivity in palladium-catalyzed reactions, a feature extensively explored in current literature. Furthermore, the ester functionality allows for straightforward derivatization, making it adaptable to various high-throughput synthesis platforms. These characteristics position CAS 105174-97-8 as a key player in the evolving landscape of specialty chemicals.

From a commercial perspective, the global market for isoxazole carboxylates has shown steady growth, driven by expanding applications in crop protection and veterinary medicine. The compound's stability under standard storage conditions and well-documented safety profile contribute to its widespread adoption. Analytical studies confirm its compatibility with common chromatographic techniques, facilitating quality control in industrial settings. As regulatory requirements for chemical traceability become more stringent, reliable compounds like Ethyl 3-bromoisoxazole-5-carboxylate gain preference in GMP-compliant production environments.

Emerging research directions for CAS 105174-97-8 include its potential in material science applications, particularly in designing organic electronic components. The conjugated system of the isoxazole ring shows promise for developing novel semiconducting materials, responding to the electronics industry's demand for specialized organic compounds. Additionally, its role in bioconjugation chemistry is being explored for creating advanced diagnostic probes and imaging agents, demonstrating the compound's expanding utility beyond traditional synthetic applications.

Quality specifications for Ethyl 3-bromoisoxazole-5-carboxylate typically include ≥98% purity by HPLC, with strict controls on residual solvents and heavy metals. Modern spectroscopic characterization techniques such as NMR and mass spectrometry provide comprehensive structural verification. The compound's physicochemical properties—including melting point range, solubility profile, and stability data—are well-documented in technical literature, supporting its reliable use in various chemical processes. These standardized parameters ensure batch-to-batch consistency, a critical factor for research reproducibility.

Handling and storage recommendations for CAS 105174-97-8 follow standard laboratory protocols for organic compounds. While not classified as hazardous under normal conditions, proper chemical safety measures should be observed, including the use of personal protective equipment. The compound demonstrates excellent shelf stability when stored in airtight containers at controlled temperatures, maintaining its reactivity for extended periods. These practical considerations contribute to its popularity among synthetic chemists working with nitrogen-containing heterocycles.

Future prospects for 3-bromoisoxazole-5-carboxylate derivatives appear promising, with ongoing investigations into their biological activities. The scaffold's presence in several clinical candidates underscores its pharmacological relevance. As computational methods for molecular docking and virtual screening advance, the demand for diverse building blocks like CAS 105174-97-8 will likely increase. This aligns with current trends toward fragment-based drug discovery and the development of privileged structures in medicinal chemistry.

From an environmental standpoint, the synthesis and application of Ethyl 3-bromoisoxazole-5-carboxylate have been evaluated for green chemistry metrics. Recent process optimizations have improved atom economy and reduced waste generation in its production. These advancements address growing concerns about sustainable chemical manufacturing while maintaining the compound's accessibility for research purposes. Such developments demonstrate the chemical industry's commitment to balancing innovation with environmental responsibility.

In conclusion, Ethyl 3-bromoisoxazole-5-carboxylate (CAS 105174-97-8) represents a significant synthetic intermediate with broad applications across multiple scientific disciplines. Its unique combination of reactivity, stability, and derivatization potential ensures continued relevance in both academic and industrial settings. As research into heterocyclic compounds progresses, this versatile molecule will undoubtedly contribute to future breakthroughs in pharmaceuticals, materials science, and beyond.

• 15055-81-9(5-Isoxazolecarboxylic Acid Methyl Ester)
• 173850-41-4(Ethyl isoxazole-5-carboxylate)
• 2091880-94-1(5-Isoxazolecarboxylic acid, 3-bromo-4-methyl-, ethyl ester)
• 272773-11-2(Methyl 3-Bromoisoxazole-5-carboxylate)
• 1392517-50-8(3-Bromoisoxazole-5-carboxylic acid tert-butyl ester)
• 1220521-36-7(3-Bromo-5-(methoxymethyl)isoxazole)
• 6567-35-7(3-Bromoisoxazole-5-carboxylic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)